Follow
Interview with Scandion Oncology
08 October 2020 - 11:32
Interview with Scandion Oncology CSO Nils Brünner during the cancer research day at Penser Bank....
Please sign in to view the full information or
Scandion Oncology A/S
Scandion is a biotechnology company. The company develops pharmaceuticals for the treatment of cancer containing drug-resistant cell clones. The leading product of the company, SCO-101, has shown to improve the effect of certain standard cancer treatments during preclinical studies. The head office of the company is located in Copenhagen....
Learn more about company